NATCO PHARMA Surges by 8%; BSE HEALTHCARE Index Up 3.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  •
  • MyStocks
MEMBER'S LOGIN

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA Surges by 8%; BSE HEALTHCARE Index Up 3.9%
Fri, 20 Mar 09:28 AM

NATCO PHARMA share price has zoomed 8% and is presently trading at Rs 544.

Meanwhile, the BSE HEALTHCARE Index is at 11,853 (up 3.9%).

Among the top Gainers in the BSE HEALTHCARE Index today are NATCO PHARMA (up 7.8%) and IPCA LABS (up 14.9%).

ERIS LIFESCIENCES LIMITED (down 1.5%) and SHILPA MEDICARE (down 5.0%) are among the top losers today.

Over the last one year, NATCO PHARMA has moved down from Rs 598 to Rs 544, registering a loss of Rs 54 (down 9.0%).

On the other hand, the BSE HEALTHCARE has moved down from 14,270 to 11,853, loss of 2,417 points (down 17.0%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 88.2%), J.B.CHEMICALS (up 60.4%) and IPCA LABS (up 57.3%).

One Stock Crorepati: The Biggest Money-Making Opportunity Available Right Now

What About the Benchmark Indices?

The BSE Sensex is at 28,687 (up 1.2%).

The top gainers among the BSE Sensex stocks today are POWER GRID (up 6.2%), ONGC (up 5.9%) and ITC (up 5.1%). Other gainers include BAJAJ AUTO (up 5.0%) and SUN PHARMA (up 4.4%). The most traded stocks in the BSE Sensex are SBI and ONGC.

In the meantime, NSE Nifty is at 8,441 (up 1.9%). The top gainers in the NSE Nifty include GAIL (up 7.9%), YES BANK (up 6.1%) and POWER GRID (up 5.6%). Other gainers include ONGC (up 5.6%) and JSW STEEL (up 5.1%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 38,363 to 28,687, registering a loss of 9,676 points (down 25.36%).

NATCO PHARMA Financial Update...

NATCO PHARMA net profit down at Rs 1 billion for the quarter ended December 2019, compared to a loss of Rs 2 billion a year ago. Net Sales declined 13.4% to Rs 4.8 billion during the period as against Rs 5.6 billion in October-December 2018.

For the year ended March 2019, NATCO PHARMA reported 7.6% decrease in net profit to Rs 6.4 billion compared to net profit of Rs 7.0 billion during FY18.

Revenue of the company grew 4.9% to Rs 21 billion during FY19.

The current Price to earnings ratio of NATCO PHARMA, based on rolling 12 month earnings, stands at 4.1x.

Archives

RSS RSS



What else is happening in the markets today? Dig in...

Advertisement
FREE Guide for You: Find the Next Crorepati Stock in this Futuristic Industry
Tanushree Banerjee, the co-head of research, just shared her latest guide: 'Find the Next Crorepati Stock in this Futuristic Industry' And she has agreed to make it available for free for a limited time. If you've not claimed your free copy, then do so now. It might not remain free for long. Click Here to Download the Guide

Equitymaster requests your view! Post a comment on "NATCO PHARMA Surges by 8%; BSE HEALTHCARE Index Up 3.9%". Click here!

  

Stock Market Updates

HINDALCO Surges by 10%; BSE 500 Index Up 6.0% (Today's Market)

Apr 7, 2020 01:18 PM

HINDALCO share price has surged by 10% and its current market price is Rs 99. The BSE 500 is up by 6.0%. The top gainers in the BSE 500 Index are HINDALCO (up 10.5%) and DR. REDDYS LAB (up 13.0%). The top losers are NMDC LTD (down 0.1%) and VINATI ORGANICS (down 0.1%).

COLGATE Surges by 5%; BSE FMCG Index Up 6.1% (Today's Market)

Apr 7, 2020 01:18 PM

COLGATE share price has surged by 5% and its current market price is Rs 1,318. The BSE FMCG is up by 6.1%. The top gainers in the BSE FMCG Index are COLGATE (up 5.5%) and NESTLE (up 8.1%). The top losers is P&G HYGIENE (down 0.2%).

ICICI BANK Surges by 10%; BSE BANKEX Index Up 8.2% (Today's Market)

Apr 7, 2020 01:14 PM

ICICI BANK share price has surged by 10% and its current market price is Rs 316. The BSE BANKEX is up by 8.2%. The top gainers in the BSE BANKEX Index are ICICI BANK (up 10.3%) and INDUSIND BANK (up 17.4%).

BSE Sensex Surges 1,850 Points; INDUSIND BANK Among Top Gainers (Today's Market)

Apr 7, 2020 01:14 PM

The BSE Sensex Surged 1,850 Points; INDUSIND BANK Among Top Gainers. Find the latest update, special reports and news on all time high gainers of BSE Sensex at equitymaster.com.

JSW STEEL Surges by 10%; BSE METAL Index Up 6.4% (Today's Market)

Apr 7, 2020 01:12 PM

JSW STEEL share price has surged by 10% and its current market price is Rs 156. The BSE METAL is up by 6.4%. The top gainers in the BSE METAL Index are JSW STEEL (up 10.2%) and JINDAL STEEL & POWER (up 17.2%). The top losers is NMDC LTD (down 0.6%).

Indian Indices Extend Rally; Sensex Zooms 1,550 Points (Today's Market)

Apr 7, 2020 12:30 pm

Share markets in India are presently trading on a strong note. Benchmark indices extended gains, tracking global cues amid signs of slowdown in coronavirus-related deaths.

View More Indian Share Market News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

One Stock that is All Charged Up for the Post Coronavirus Rebound(The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak(Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

S&P BSE SENSEX


Apr 7, 2020 01:27 PM

OTHER USEFUL LINKS

MARKET STATS


ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
  • Get Equitymaster Android App on Google Play
  • Get Equitymaster iOS App on App Store
FOLLOW

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.